5-(3′-hydroxyphenyl)-γ-valerolactone(21618-91-7)
- Name: 5-(3′-hydroxyphenyl)-γ-valerolactone
- Synonyms:5-(3′-hydroxyphenyl)-γ-valerolactone
- Molecular Formula:
- Molecular Weight:192.214
- CAS Registry Number:21618-91-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.21618-91-7 5-[(3-hydroxyphenyl)methyl]oxolan-2-one
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.21618-91-7 5-[(3-hydroxyphenyl)methyl]oxolan-2-one;21618-91-7
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 920-88-7/heptane-4-sulfonyl chloride
- 58306-20-0/2-(N',N''-Bismethoxycarbonylguanidino)-5-phenylthio-butyranilid
- 855479-30-0/methyl 3-(acetylamino)-4'-[2-[benzyl[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylcarboxylate
- 855778-38-0/(Z)-methyl 3-(4-amino-3,5-dimethylphenyl)-2-(benzyloxycarbonylamino)acrylate
- 70993-60-1/C24H28N4O4S2
- 82929-48-4/2-hydroxy-N-(4-nitrobenzoyl)benzamide
- 1055424-84-4/5-benzo[1,3]dioxol-5-yl-2-methyl-3-(3,4,5-trimethoxy-phenyl)-2,3-dihydro-isoxazole-4-carboxylic acid ethyl ester
- 1276109-94-4/N-(2-(3-aminopropoxy)-4-(4-(2-(3-hydroxyphenyl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)-1,2,3,6-tetrahydropyridine-1-carbonyl)phenyl)acrylamide trifluoroacetate
- 1310740-73-8/(R)-3-(hexylthio)-2-(3-nitrophenylsulfonamido)propanoic acid
- 1312770-13-0/tert-butyl 4-[(1R)-1-({[(6S)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1-(2,4,6-trimethoxybenzyl)-1,4-diazepan-1-yl]carbonyl}amino)butyl]-2-nitrobenzoate
- 863566-40-9/{5-[2-(4-fluorophenoxy)ethyl]tetrahydro-2H-pyran-2-yl}methanol
- 78539-82-9/2-Imino-1-(5-methyl-thiophen-2-yl)-2-phenyl-ethanone
- 168158-25-6/2-{(R)-3-Methyl-1-[((S)-methylcarbamoyl-phenyl-methyl)-carbamoyl]-butyl}-malonic acid dibenzyl ester
- 1366131-49-8/1-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine
- 1616556-60-5/C32H41NO5
- 1593705-02-2/(S)-1-cyclopropyl-7-(4-(3,11-dioxo-1,13-diphenyl-2,12-dioxa-4,10-diazatridecanecarbonyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1092800-62-8/5-(5-prop-2-ynylaminomethylfuran-2-yl)pent-4-yn-2-ol
- 104245-80-9/2,4-dinitrophenyl 4-acetamidobenzoate
- 212322-80-0/1-methyl-2-[N-(4-cyanophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(4-fluorophenyl)-N-(2-ethoxycarbonylethyl)-amide
- 21618-91-7/5-(3′-hydroxyphenyl)-γ-valerolactone
- 1067884-42-7/(2'Z-3'E)-6-bromoindirubin-3'-[O-(2-morpholin-4-ylethyl)oxime]
- 1146963-03-2/methyl 8-azido-1,4,5,6,9-penta-O-benzyl-8,10-dideoxy-3-thio-D-ribo-β-L-gluco-dec-3-ulopyranoside
- 1024617-65-9/3-(4-hydroxybutyl)-5'-O-(tert-butyldiphenylsilyl)-2',3'-O-(isopropylidene)uridine
- 724-43-6/ethyl 1-acetyl-1H-indazole-6-carboxylate
- 88972-53-6/O-[2-(2'-methylphenyl)-5,5-dimethyl-3-oxo-1-cyclohexenyl]-O-ethyl-S-n-propyl thiophosphate
- 135656-77-8/2-(1,1-dimethylallyl)-2,3-dihydro-O-benzylcoumaric acid
- 54254-92-1/diethylammonium 4-methylbenzenecarbodithioate
- 145801-83-8/N-(5,5-dimethyl-3-oxocyclohex-1-enyl)-N-hexylpent-4-enamide
- 1462951-41-2/7-nitro-8-(propan-2-yloxy)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
- 1591827-49-4/3-chloro-5-((1-((5-(4-fluorophenyl)-6-oxo-1-(tetrahydro-2H-pyran-2-yl)-1,6-dihydropyridazin-3-yl)methyl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyrimidin-5-yl)oxy)benzonitrile